Atyr Pharma Inc (NASDAQ:ATYR) has a beta value of 0.92 and has seen 1.13 million shares traded in the last trading session. The company, currently valued at $278.13M, closed the last trade at $3.13 per share which meant it lost -$0.13 on the day or -3.99% during that session. The ATYR stock price is -48.88% off its 52-week high price of $4.66 and 54.63% above the 52-week low of $1.42. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.28 million shares traded. The 3-month trading volume is 1.29 million shares.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Sporting -3.99% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ATYR stock price touched $3.13 or saw a rise of 20.56%. Year-to-date, Atyr Pharma Inc shares have moved -13.54%, while the 5-day performance has seen it change -14.95%. Over the past 30 days, the shares of Atyr Pharma Inc (NASDAQ:ATYR) have changed -19.12%. Short interest in the company has seen 6.92 million shares shorted with days to cover at 3.39.
Atyr Pharma Inc (ATYR) estimates and forecasts
The company’s shares have gained 81.98% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 751.06%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.28% over the past 5 years.
ATYR Dividends
Atyr Pharma Inc is expected to release its next earnings report on 2025-Mar-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
Insiders own 2.24% of the company shares, while shares held by institutions stand at 61.92% with a share float percentage of 63.33%. Investors are also buoyed by the number of investors in a company, with Atyr Pharma Inc having a total of 89.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund . As of Oct 31, 2024 , the former fund manager holds about 8.83% shares in the company for having 7.85 shares of worth $24.57 million while later fund manager owns 6.62 shares of worth $20.72 million as of Oct 31, 2024 , which makes it owner of about 7.45% of company’s outstanding stock.
